AM15: Benefits, Dosage Protocols, Mechanism, Warnings & Research

🔬 What is BAM15?

BAM15 (N5,N6-bis(2-fluorophenyl)-1,2,5-oxadiazolo[3,4-b]pyrazine-5,6-diamine) is a novel mitochondrial uncoupler. Unlike traditional uncouplers like DNP, BAM15 uniquely increases mitochondrial respiration without elevating body temperature, making it a promising non-toxic candidate for fat loss, insulin sensitization, and age-related disease mitigation [1].

⚙️ Mechanism of Action:

BAM15 works by disrupting the mitochondrial proton gradient — the same gradient used to produce ATP. Instead of ATP synthesis, the energy is dissipated as heat (thermogenesis), leading to:

Increased energy expenditure

Decreased ATP production efficiency

Enhanced fatty acid oxidation

Reduced reactive oxygen species (ROS) production [2]

BAM15 does not rely on the β-adrenergic system, minimizing cardiovascular stimulation and making it a more targeted mitochondrial uncoupler compared to stimulants.

⚠️ Who Should NOT Take BAM15: (Warnings)

While BAM15 is a research chemical not approved for human use, based on its mitochondrial uncoupling properties and murine data, the following individuals or models should be approached with caution:

Individuals with cardiovascular conditions: mitochondrial uncoupling can theoretically stress the heart if misused

Those with underweight BMI: BAM15 increases caloric burn regardless of caloric intake

Hypoglycemic-prone individuals: may further enhance insulin sensitivity and glucose disposal

Pregnancy or lactation models: mitochondrial agents may disrupt fetal development

Children or adolescents: unstudied in developing systems

⚖️ Available Doses & Capsule Options

Currently available research-grade capsule forms:

50 mg capsule

100 mg capsule

Typical research dosage in animal models: 1-5 mg/kg/day, translating (with caveats) to ~50–200 mg/day for a 70–90 kg human in hypothetical models via allometric scaling.

🕑 Time of Day Considerations:

Morning dosing is preferred due to BAM15’s potential for increasing thermogenesis and energy expenditure.

Avoid late-night dosing unless studying effects on nighttime metabolism; may interfere with sleep due to metabolic stimulation.

Fasted administration may enhance lipolysis and fat oxidation effects.

🧊 Storage

Store BAM15 capsules at room temperature, away from light and moisture.

For powder forms, seal tightly and refrigerate if not used within 30 days.

Keep out of reach of children, pets, and non-researchers.

🧾 Disclaimer

This information is for educational and research purposes only. BAM15 is not FDA-approved for human consumption, diagnosis, or treatment of any disease. This is not medical advice. Consult with a licensed physician before considering any compound or therapy. All use of BAM15 should be conducted under appropriate research protocols and ethics guidelines.

📚 Primary Literature & References

Alex S. et al. (2020). BAM15, a Mitochondrial Uncoupler, Reverses Diet-Induced Obesity and Insulin Resistance in Mice Without Affecting Food Intake. Nature Communications, 11, 2397. https://doi.org/10.1038/s41467-020-16147-5

Bertholet AM et al. (2019). H(+)-independent mitochondrial uncoupling mechanisms. Cell Metabolism, 29(2), 248-262. https://doi.org/10.1016/j.cmet.2018.10.002

Kang S et al. (2021). The role of mitochondrial uncoupling in regulating metabolism and aging. Trends in Endocrinology & Metabolism, 32(3), 181-194.

Ostojic SM. (2022). Mitochondrial uncoupling agents as regulators of energy metabolism in obesity and related disorders. Nutrients, 14(3), 543. https://doi.org/10.3390/nu14030543

Acín-Pérez R. et al. (2021). Mitochondrial oxidative stress is a key determinant of mitochondrial uncoupling. Science, 374(6571), eabj0180.